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PCardiac Rhythm Disorders
rolonged QTc Interval and Risk of Sudden
ardiac Death in a Population of Older Adults
abine M. J. M. Straus, MD, PHD,*†‡ Jan A. Kors, PHD,† Marie L. De Bruin, PHD,§
ornelis S. van der Hooft, MD,† Albert Hofman, MD, PHD,* Jan Heeringa, MD,*
aap W. Deckers, MD, PHD,* J. Herre Kingma, MD, PHD,¶ Miriam C. J. M. Sturkenboom, PHD,*†
runo H. Ch. Stricker, PHD,* Jacqueline C. M. Witteman, PHD*
otterdam, the Hague, Utrecht, and Groningen, the Netherlands
OBJECTIVES This study sought to investigate whether prolongation of the heart rate-corrected QT (QTc)
interval is a risk factor for sudden cardiac death in the general population.
BACKGROUND In developed countries, sudden cardiac death is a major cause of cardiovascular mortality.
Prolongation of the QTc interval has been associated with ventricular arrhythmias, but in
most population-based studies no consistent association was found between QTc prolonga-
tion and total or cardiovascular mortality. Only very few of these studies specifically addressed
sudden cardiac death.
METHODS This study was conducted as part of the Rotterdam Study, a prospective population-based
cohort study that comprises 3,105 men and 4,878 women aged 55 years and older. The QTc
interval on the electrocardiogram was determined during the baseline visit (1990 to 1993) and
the first follow-up examination (1993 to 1995). The association between a prolonged QTc
interval and sudden cardiac death was estimated using Cox proportional hazards analysis.
RESULTS During an average follow-up period of 6.7 years (standard deviation, 2.3 years) 125 patients
died of sudden cardiac death. An abnormally prolonged QTc interval (450 ms in men,
470 ms in women) was associated with a three-fold increased risk of sudden cardiac death
(hazard ratio, 2.5; 95% confidence interval, 1.3 to 4.7), after adjustment for age, gender, body
mass index, hypertension, cholesterol/high-density lipoprotein ratio, diabetes mellitus,
myocardial infarction, heart failure, and heart rate. In patients with an age below the median
of 68 years, the corresponding relative risk was 8.0 (95% confidence interval 2.1 to 31.3).
CONCLUSIONS Abnormal QTc prolongation on the electrocardiogram should be viewed as an independent
risk factor for sudden cardiac death. (J Am Coll Cardiol 2006;47:362–7) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.067American College of Cardiology Foundation
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vn developed countries, sudden cardiac death is one of the
ajor causes of cardiovascular mortality. Sudden cardiac
eath accounts for almost half of all coronary heart disease
eaths and is often the first and only manifestation of
oronary heart disease (1–3). According to the most recent
efinition, sudden cardiac death is a natural death attribut-
See page 368
ble to cardiac causes, heralded by abrupt loss of con-
ciousness, within one hour after the onset of acute
ymptoms, or an unwitnessed, unexpected death of some-
ne seen in a stable medical condition 24 h previously
ith no evidence of a non-cardiac cause (2,3). Much of
his mortality is assumed to be caused by ventricular
From the *Department of Epidemiology and Biostatistics, Erasmus Medical
enter, Rotterdam; †Department of Medical Informatics, Erasmus Medical Center,
otterdam; ‡Medicines Evaluation Board, the Hague, §Department of Pharmaco-
pidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences,
trecht; Inspectorate for Healthcare, the Hague; and the ¶Department of Clinical
harmacology, University of Groningen, Groningen, the Netherlands.a
Manuscript received May 22, 2005; revised manuscript received July 11, 2005,
ccepted August 1, 2005.achyarrhythmias, and evaluation of risk factors is a major
hallenge when searching for treatments to reduce this
isk (4). In the search for non-invasive risk factors to
redict mortality, the heart rate corrected QT (QTc)
nterval has been studied extensively (4 –14). The QT
nterval on the surface electrocardiogram (ECG) repre-
ents the time from onset of ventricular depolarization to
ompletion of repolarization, and prolongation has been
ssociated with ventricular arrhythmias that may trigger
entricular fibrillation and sudden cardiac death (15).
here is an ongoing debate on the clinical significance of
prolonged QTc interval (14,16,17). Several large
opulation-based studies evaluating the association be-
ween QTc interval and mortality did not find a consis-
ent association between QTc prolongation and total or
ardiovascular mortality (4,7–9,11,12,18). Only a few
pecifically addressed sudden cardiac death, and when
hey did, the number of cases was often too small to
etect significant differences (5,8,10).
We investigated whether prolongation of the QTc inter-
al is an independent risk factor for sudden cardiac death in
population of older adults.
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etting, study population, and baseline data collection.
he study is embedded in the Rotterdam Study, a prospec-
ive population-based cohort study, which started between
990 and 1993. All inhabitants of a suburb in Rotterdam,
mmoord, aged 55 years and over (10,275), were invited to
articipate. Of these, 7,983 (78%) gave written informed
onsent and took part in the baseline examination. Objec-
ives and methods have been described in detail elsewhere
19). All participants were visited at home for a standardized
uestionnaire, and 7,151 were subsequently examined at the
esearch center. A second visit took place between 1993
hrough 1995. For the present study, follow-up started at
aseline and lasted until January 1, 2000.
Information on smoking was obtained during the home
nterview of the Rotterdam Study. During the research
enter visit, non-fasting blood samples were obtained,
erum total cholesterol was determined by an enzymatic
rocedure, and high-density lipoprotein was measured sim-
larly after precipitation of the non–high-density lipopro-
ein fraction (20). Body mass index was computed as weight
ivided by height squared. Hypertension was defined as the
se of antihypertensive medication for high blood pressure,
r a systolic blood pressure 160 mm Hg and/or diastolic
lood pressure 100 mm Hg (21). Diabetes mellitus was
efined as the use of blood glucose-lowering medication
nd/or non-fasting or post-load serum glucose level of
11.1 mmol/l (22). A history of myocardial infarction was
ssessed by self-report checked with records from general
ractitioners or cardiologists and/or electrocardiographic
vidence. All reported myocardial infarctions were verified,
nd assessment has been described in detail earlier (23).
ssessment of heart failure has also been described in detail
arlier. Briefly, prevalent cases were assessed by screening all
edical records for at least two signs and symptoms
uggestive of heart failure or use of medication for heart
ailure and review of all hospital discharge letters. Cases of
ncident heart failure were obtained by continuous moni-
oring (24,25). The ankle-arm index (AAI) is the ratio of
ystolic blood pressure at the ankle to systolic blood pressure
n the arm (26).
The Medical Ethics Committee of the Erasmus Medical
enter, Rotterdam approved the study.
utcomes assessment. Participants in the Rotterdam
tudy are continuously monitored for major events, includ-
Abbreviations and Acronyms
AAI  ankle-arm index
CI  confidence interval
HR  hazard ratio
LBBB  left bundle branch block
SD  standard deviation
QTc interval  heart rate-corrected QT intervalng heart failure, myocardial infarction, and death. Infor- (ation on vital status is obtained from municipal health
uthorities in Rotterdam and general practitioners. In case
f a fatal event, general practitioners filled in a questionnaire
elating to the circumstances of the death, including time
ince first symptoms until death, most likely cause of death,
nd time and place of death. Subsequently, research assis-
ants gathered information about these events at the general
ractitioners’ offices. Questionnaires and a copy of the
edical records were used to assess whether death could be
lassified as sudden cardiac death using the most recent
efinition: natural death attributable to cardiac causes,
eralded by abrupt loss of consciousness, within one hour
fter onset of acute symptoms, or an unwitnessed, unex-
ected death of someone seen in a stable medical condition
24 h previously with no evidence of a non-cardiac cause
2,3). If death was witnessed and occurred within one hour
fter the start of symptoms, we assumed it to be a sudden
ardiac death, without additional review of medical records.
n case of an unwitnessed death, evidence of cardiac causes
as searched for, using all available information. Two
esearch physicians coded all events independently accord-
ng to the International Classification of Diseases-10th
dition (sudden cardiac death: I.46 [27]). In case of dis-
greement, consensus was sought. Finally, a cardiologist,
hose judgment was considered decisive, reviewed all
vents.
CG interpretation and measurement. A 10-s 12-lead
esting ECG (on average, 8 to 10 beats) was recorded with
n ACTA electrocardiograph (ESAOTE, Florence, Italy)
t a sampling frequency of 500 Hz and stored digitally. All
CGs were processed by the Modular ECG Analysis
ystem (MEANS) to obtain ECG measurements. The
EANS determines common onsets and offsets for all 12
eads together on one representative averaged beat, with the
se of template matching techniques, and has been evalu-
ted extensively (28–30). The MEANS program deter-
ines the QT interval from the start of the QRS complex
ntil the end of the T-wave. To adjust for heart rate, the
azett formula (QTc  QT/RR) was used (31).
The most recent European regulatory guideline docu-
ent, based on the opinion of an ad-hoc expert group, was
sed to categorize QTc prolongation into three gender-
pecific categories. For women, the cutoff points were450
s (normal), 451 to 470 ms (borderline), and 470 ms
prolonged), and for men430 ms (normal), 431 to 450 ms
borderline), and 450 ms (prolonged) (32). In addition,
e used different QTc thresholds varying from 440 to 470
s, based on literature (4,5,7–10,12,13,18,33,34).
Digitally stored ECGs of 6,134 participants (86% of the
articipants who visited the research center) were available
t the first visit. At the second visit, 4,415 (70%) digitally
tored ECGs were available. Missing ECGs were mainly
ttributable to temporary technical problems with ECG
ecording. The diagnosis of left bundle branch block
LBBB) was based on established criteria (35).
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QTc Prolongation and Sudden Cardiac Death January 17, 2006:362–7tatistical analysis. Differences in baseline characteristics
etween participants with normal (male, 430 ms; female,
450 ms), borderline (male, 431 to 450 ms; female, 451 to
70 ms), and abnormal (male, 451 ms; female, 471 ms)
Tc interval prolongation were examined with analysis of
ovariance. The hazard ratio (HR) (95% confidence interval
CI]) of the association between prolonged QTc interval
nd sudden cardiac death was estimated using a Cox
roportional hazards analysis. The QTc interval at the time
f the first visit was taken as the independent variable. For
hose participants who also had a second ECG at the
ollow-up visit, the results of follow-up QTc interval mea-
urements were included in the analyses. All information
oncerning co-morbidities (hypertension, diabetes mellitus,
yocardial infarction, heart failure) was also updated at that
ime. Potential confounders were included in the multivar-
ate model: age, gender, body mass index, hypertension,
holesterol/high-density lipoprotein ratio, diabetes mellitus,
yocardial infarction, heart failure, AAI. Because the Ba-
ett formula tends to undercorrect for lower heart rates and
vercorrect for higher heart rates, we also included heart rate
n the model. Sensitivity analyses were performed using
ifferent QTc cutoff points. Because LBBB can cause
econdary repolarization changes and atrial fibrillation can
ause difficulties in measuring the QT interval, analyses also
ere performed after exclusion of patients with LBBB and
trial fibrillation at baseline. We also assessed the risk of
udden cardiac death in participants with at least one
ardiovascular risk factor at baseline. We added interaction
erms of QTc with age, hypertension, smoking, diabetes
ellitus, myocardial infarction, and heart failure in the
odel. Finally, we calculated the attributable risk percent as:
HR  1/HR  100) (36).
ESULTS
he mean follow-up time was 6.7 years (standard deviation
Table 1. Baseline Characteristics of the Study
Prolongation at Baseline*
Characteristic
All
(n  6,134) (n
Age 69.2 (9) 6
Female gender 59.6%
Smoking 22.7%
Total/HDL cholesterol ratio 5.2
Body mass index (SD) 26.3 (3.7) 2
Blood pressure
Systolic (mm Hg) 139.4 (22.3) 13
Diastolic (mm Hg) 73.5 (11.6) 7
Hypertension 33.6%
Diabetes mellitus 10.5%
Myocardial infarction 6.3%
Heart failure 3.2%
Values are means (SD) for continuous variables and percentag
normal men 430 ms; women 450 ms; borderline men 43
471 ms.
HDL  high-density lipoprotein; SD  standard deviatSD], 2.3 years). During follow-up, 1,407 (22.8%) partici- mants died and 67 were lost to follow-up. We identified 125
udden cardiac deaths, yielding an incidence rate of approx-
mately 3 per 1,000 person-years. Table 1 shows baseline
haracteristics of all participants with a normal, borderline,
nd abnormal QTc interval. The prevalence of cardiovas-
ular comorbidity increased with an increasing QTc inter-
al. Women had a significantly longer QTc interval (435
s; SD, 26) than men (426 ms; SD, 28). The characteristics
f the cases and non-cases are presented in Table 2. Cases
ad a significantly longer mean QTc interval (441.9 ms; SD,
3.0) compared with the non-cases (431.3 ms; SD, 27.1). In
ur population we identified 118 patients (1.9%) with
BBB and 168 (2.7%) with atrial fibrillation.
Abnormal QTc prolongation was associated with a more
han two-fold increase in the risk of sudden cardiac death
ompared with reference QTc values in the fully adjusted
odel. The relative risk was most pronounced in the lower
ge group (ages 55 to 68 years) (Table 3). In Figure 1, the
aplan-Meier log survival plot of the risk of sudden cardiac
eath in relation to the QTc interval is shown.
In patients with at least one cardiovascular risk factor at
aseline, abnormal QTc prolongation was associated with a
our-fold increase in the risk of sudden cardiac death (HR,
.3; 95% CI, 2.2 to 8.6). After exclusion of patients with
BBB or atrial fibrillation, the risk of sudden cardiac death
as significantly increased in both patients with borderline
rolonged QTc interval (HR, 1.9; 95% CI, 1.0 to 3.7) as
ell as in patients with an abnormally prolonged QTc
nterval (HR, 2.7; 95% CI, 1.3 to 5.4). Because many
tudies used QTc interval classifications into two categories,
e also analyzed QTc prolongation using cutoff points
arying from 440 ms to 470 ms (Fig. 2). Using 440 ms as a
utoff point of QTc interval prolongation, we observed a
ignificant increase in the risk of sudden cardiac death after
djustment for age and gender (HR, 2.3; 95% CI, 1.4 to
.8), and this risk remained increased in the fully adjusted
lation Stratified by Category of QTc
al
,344)
Borderline
(n  1,109)
Abnormal
(n  681) p
8.9) 70.1 (8.8) 73.5 (9.0) 0.001
% 49.4% 42.4% 0.001
% 27.1% 22.8% 0.001
5.3 5.4 0.01
.6) 26.4 (3.8) 26.7 (3.8) ns
21.9) 142.2 (22.2) 145.1 (23.4) 0.001
11.3) 75.3 (12.1) 75.0 (12.1) 0.001
% 39% 44.9% 0.001
% 14% 17.8% 0.001
% 6.6% 12.9% 0.001
% 3.6% 9.5% 0.001
dichotomous variables. *Classification of QTc prolongation:
ms; women 451–470 ms; abnormal men 451 ms; women
Tc  heart rate corrected QT interval.Popu
Norm
 4
8.4 (
64.9
21.5
5.2
6.2 (3
7.8 (
2.9 (
30.6
8.5
5.2
2.1
es for
1–450odel (HR, 1.3; 95% CI, 0.9 to 1.9). None of the
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January 17, 2006:362–7 QTc Prolongation and Sudden Cardiac Deathnteractions we tested for were statistically significant. The
ncrease in risk of sudden cardiac death corresponded with
n attributable risk proportion of 0.6, meaning that in our
tudy 60% of all cases of sudden cardiac death were
ssociated with an abnormally prolonged QTc interval.
ISCUSSION
n this population-based study, an abnormally prolonged
Tc interval was associated with a more than two-fold
ncreased risk of sudden cardiac death. In patients below the
edian age of 68 years, a prolonged QTc interval was
ssociated with an eight-fold increased risk. Risk estimates
ere independent of cardiovascular risk factors. In our
nalyses, we used European regulatory guidelines to classify
Tc prolongation in three gender-specific categories (32).
f we classified the QTc interval according to previously
Table 2. Baseline Characteristics of Non-Case
Characteristics at Baseline
Non-Cases
(n  6,009)
Age 69.1 (9)
Female gender 59.9%
Smoking 22.7%
Cholesterol/HDL ratio 5.2
Body mass index 26.3
Hypertension 33.2%
Diabetes mellitus 10.3%
Myocardial infarction 5.8%
Heart failure 2.9%
QTc interval 431.25 (27.1)
Values are means (SD) for continuous variables and percenta
for age and gender (age: gender-adjusted and gender: age-ad
CI confidence interval; HDL high-density lipoprotei
 standard deviation.
able 3. QTc Prolongation and Risk of Sudden Cardiac Death
QTc Prolongation
HR
(95% CI)*
HR
(95% CI)†
ormal (n  4,344) 1 (reference) 1 (reference)
orderline (n  1,109) 2.3 (1.3–4.2) 1.6 (0.9–3.1)
bnormal (n  681) 3.7 (2.0–6.9) 2.5 (1.3–4.7)
Median age (55–68 yrs)
Normal (n  2,341) 1 (reference) 1 (reference)
Borderline (n  514) 5.0 (1.5–16.8) 3.7 (1.1–14.0)
Abnormal (n  212) 9.8 (2.7–35.1) 8.0 (2.1–31.3)
Median age (68 yrs)
Normal (n  2,003) 1 (reference) 1 (reference)
Borderline (n  595) 1.7 (0.9–3.6) 1.3 (0.6–2.7)
Abnormal (n  469) 2.8 (1.4–5.9) 2.1 (1.0–4.4)
en
Normal (n  1,523) 1 (reference) 1 (reference)
Borderline (n  561) 2.4 (1.0–5.3) 1.8 (0.8–4.1)
Abnormal (n  392) 3.9 (1.8–8.4) 2.6 (1.1–5.8)
omen
Normal (n  2,821) 1 (reference) 1 (reference)
Borderline (n  548) 2.3 (0.9–5.9) 1.3 (0.5–3.7)
Abnormal (n  289) 3.5 (1.3–9.8) 2.5 (1.0–7.1)
Adjusted for age and gender (adjusted for age in gender-stratified analyses and for
ender in age-stratified analyses). †Adjusted for age, gender, smoking, cholesterol/
DL ratio, body mass index, hypertension, diabetes mellitus, myocardial infarction,eart failure, and heart rate.
Reference  reference value; other abbreviations as in Table 2.
F
ised cutoff levels, we observed an increased risk of sudden
ardiac death starting at a cutoff point of 440 ms. The AAI
s considered a marker of atherosclerosis influenced not only
y the presence of plaques but also by hemodynamic factors
nd vascular factors (37). Because subclinical atherosclerotic
isease can influence the QTc interval, we analyzed the
ffect of AAI on the risk of sudden cardiac death. The
djustment did not change the point estimates.
Results of several epidemiologic studies evaluating total
nd cardiovascular mortality in relation to QTc prolonga-
ion have yielded conflicting results (4,7–12,18,38), and
nly a few specifically addressed sudden cardiac death (5,8).
n patients referred for Holter monitoring, a QTc interval of
ore than 440 ms doubled the risk of sudden cardiac death
5). In the Zutphen study, QTc prolongation of 420 ms or
ore was associated with a three-fold increased risk of
udden cardiac death (HR, 3.0; 95% CI, 1.0 to 8.9) in
lderly men (ages 65 to 85 years), but not in men ages 40 to
Cases of Sudden Cardiac Death
CD Cases
(n  125) HR* (95% CI) p
74.3 (8) 1.1 (1.0–1.1) 0.000
44.8% 0.4 (0.3–0.6) 0.000
17.6% 1.4 (0.9–2.7) 0.2
5.5 1.1 (1.0–1.2) 0.04
26.1 0.9 (0.9–1.0) 0.7
56.0% 2.4 (1.7–3.5) 0.000
23.2% 2.4 (1.6–3.4) 0.000
28% 4.6 (3.1–6.9) 0.000
15.2% 4.5 (2.7–7.5) 0.000
41.9 (33.0) 1.01 (1.00–1.02) 0.000
r dichotomous variables. QTc interval in ms. *HR adjusted
)
ol/l); HR hazard ratio; SCD sudden cardiac death; SDs and
S
4
ges fo
justedigure 1. Kaplan-Meier log survival plot of heart rate corrected QT (QTc)
nterval prolongation and sudden cardiac death.
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ssociation of baseline QTc prolongation with total mortal-
ty, sudden death, or coronary mortality (9). The Cardio-
ascular Health Study, on the other hand, showed an
ssociation between a QTc interval of 450 ms and total
ortality, and in the Strong Heart Study, a QTc interval of
460 ms was associated with a two-fold increased risk of
ardiac and total mortality (12). In the Rotterdam Study, we
reviously found that QTc prolongation (440 ms) was
ssociated with an increased risk of total and cardiovascular
ortality (7). In this study, however, shorter follow-up and
ne baseline ECG were used, and the relationship with
udden cardiac death was not specifically evaluated. The risk
f sudden cardiac death in the present study was higher in
he younger population. This may be partly explained by
epletion of susceptible patients at an older age. The
roportion of sudden cardiac deaths attributable to a pro-
onged QTc interval is larger in the younger age category.
he absolute risk of sudden cardiac death, however, in-
reases with age (39,40).
The strength of our study lies in the fact that data were
vailable on a large group of patients. The relatively long
ollow-up period enabled us to take advantage of the fact
hat a large part of the participants underwent two ECGs.
here was little loss to follow-up and detailed information
n cardiovascular risk factors. Conflicting results in earlier
tudies may be partly explained by differences in definition
f sudden cardiac death, differences in populations, classi-
cation of QTc prolongation, or use of general rather than
ender-specific QTc cutoff points. To our knowledge, this
tudy is the first to use gender-specific classification based
n a European guideline in a population-based study (32).
n addition, in all studies QTc prolongation was based on
ne baseline ECG and related to outcomes that usually
ccurred many years later.
Nevertheless, our study also has some limitations. First,
e cannot exclude that misclassification of outcomes oc-
igure 2. Risk of sudden cardiac death (SCD) at different heart rate
orrected QT (QTc) interval cutoff points. *Adjusted for age, gender, body
ass index, cholesterol/high-density lipoprotein ratio, smoking, hyperten-
ion, diabetes, myocardial infarction, and heart rate. CI  confidence
nterval; HR  hazard ratio.urred. We were, however, able to take advantage of the facthat in most cases complete information regarding the facts
urrounding death was available, including a detailed ques-
ionnaire and in many cases the time between start of
ymptoms and death. Second, misclassification of exposure
ay have occurred because we related sudden cardiac death
o QTc prolongation measured before the event, and the
Tc interval could have changed in the meantime. Finally,
ur study population consisted of patients aged 55 years and
lder. Whether our findings also apply to other age groups
equires further study.
In conclusion, the results of our study show that abnor-
al QTc prolongation on the ECG should be viewed as an
ndependent risk factor for sudden cardiac death. Two-
hirds of the cases of sudden cardiac death are associated
ith an abnormal prolongation of the QTc interval.
eprint requests and correspondence: Dr. Bruno H. Ch.
tricker, Department of Epidemiology and Biostatistics, Erasmus
edical Center, P.O. Box 1738, 3000 DR Rotterdam, the
etherlands. E-mail: b.stricker@erasmusmc.nl.
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